NewsDialy
An FDA advisory panel voted Friday to allow compounding pharmacies to produce epitalon while narrowly recommending against the same permission for emideltide.
Compounding pharmacies, for those unfamiliar with the term, are facilities licensed to prepare customized drug formulations outside the standard commercial supply chain.
The pair of decisions closed out a two-day session in Washington that moved Health Secretary Robert F. one step closer to his stated mission of making unapproved compounds more available to Americans.
What a compounding pharmacy can and cannot do A compounding pharmacy fills a specific gap in the drug supply.
Keep reading